Q2 2025 Holdings
Filed 2025-08-14 | 56 holdings | $502.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $39.0M | 1,499,942 | 7.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $34.6M | 321,800 | 6.9% |
| Natera Inc(NTRA) | COM | 632307104 | $33.7M | 199,300 | 6.7% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $32.5M | 1,742,902 | 6.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $18.9M | 355,000 | 3.8% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $18.7M | 106,000 | 3.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $18.4M | 210,500 | 3.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $17.7M | 89,700 | 3.5% |
| Hinge Health Inc(HNGE) | CL A | 433313103 | $16.7M | 322,344 | 3.3% |
| Intuitive Surgival Inc(ISRG) | COM NEW | 46120E602 | $14.7M | 27,100 | 2.9% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $13.4M | 650,000 | 2.7% |
| Repligen Corp(RGEN) | COM | 759916109 | $13.2M | 106,500 | 2.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $12.0M | 29,600 | 2.4% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $11.6M | 689,500 | 2.3% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $11.3M | 1,127,186 | 2.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $10.2M | 1,064,500 | 2.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $10.0M | 32,000 | 2.0% |
| Mckesson Corp(MCK) | COM NEW | 58155Q103 | $9.9M | 13,500 | 2.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $9.9M | 94,500 | 2.0% |
| Cencora Inc(COR) | COM | 03073E105 | $9.8M | 32,800 | 2.0% |
| Healthequity Inc(HQY) | COM | 42226A107 | $9.6M | 92,000 | 1.9% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $9.1M | 74,000 | 1.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $8.4M | 228,600 | 1.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $7.2M | 134,000 | 1.4% |
| Omada Health Inc(OMDA) | COM | 68170A108 | $7.1M | 390,600 | 1.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $7.0M | 409,400 | 1.4% |
| Humana Inc(HUM) | COM | 444859102 | $6.7M | 27,600 | 1.3% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $6.4M | 1,858,596 | 1.3% |
| Organon & Co(OGN) | COM | 68622V106 | $6.2M | 640,000 | 1.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.0M | 140,000 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.9M | 59,000 | 1.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM NEW | 558868105 | $5.8M | 19,000 | 1.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.6M | 154,000 | 1.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $4.9M | 7,477,255 | 1.0% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $3.9M | 352,124 | 0.8% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $3.9M | 5,615,811 | 0.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $3.8M | 268,000 | 0.7% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $3.7M | 60,000 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.4M | 107,891 | 0.7% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $3.2M | 33,800 | 0.6% |
| Syndax Pharmaceuticals Inc(SNDX)Call | COM | 87164F105 | $3.2M | 340,000 | 0.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.9M | 207,000 | 0.6% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $2.8M | 65,000 | 0.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $2.7M | 32,000 | 0.5% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $2.5M | 15,000 | 0.5% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $2.4M | 140,000 | 0.5% |
| Kezar Life Sciences Inc(KZR) | COM NEW | 49372L209 | $2.3M | 502,600 | 0.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $2.2M | 232,000 | 0.4% |
| Moonlake Immunotherapeutics(MLTX) | A ORD | 61559X104 | $1.8M | 39,000 | 0.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $1.8M | 243,162 | 0.4% |